Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (50.0%)
N/A1 (50.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
completed

Apoptosis Proteins and Endothelial Dysfunction in Patients With Atherosclerosis of Peripheral Arteries

NCT04502849
completed

Prospective Observation Study of Outcome of Interventions for Critical Ischemia

NCT01794494
recruitingnot_applicable

Prospective Case-control Study in Patients With PAA

NCT04188808
completedphase_3

The Carotid and Middle Cerebral Artery Occlusion Surgery Study

NCT01758614

Clinical Trials (4)

Showing 4 of 4 trials
NCT04502849

Apoptosis Proteins and Endothelial Dysfunction in Patients With Atherosclerosis of Peripheral Arteries

Completed
NCT01794494

Prospective Observation Study of Outcome of Interventions for Critical Ischemia

Completed
NCT04188808Not Applicable

Prospective Case-control Study in Patients With PAA

Recruiting
NCT01758614Phase 3

The Carotid and Middle Cerebral Artery Occlusion Surgery Study

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4